MI SB0641

Requires the Michigan Department of Health and Human Services to ensure accessible, quality health care for Medicaid-enrolled individuals with sickle cell disease or thalassemia through managed care organizations.

Mandates Medicaid managed care organizations implement quality strategies by fiscal year 2024 that include member identification within 180 days, care coordination, primary care provider training, and annual performance measures with incentive payments.

Requires the department to develop a state sickle cell disease surveillance system annual report to legislative committees and publish findings on service gaps, access trends, therapy uptake, health outcomes, and insurance enrollment disparities.

Directs the department to contract with a publicly funded university by January 1, 2022, to develop comprehensive assessment tools for screening sickle cell disease and thalassemia patients for comorbidities, medical history, psychosocial needs, and barriers to treatment.

Requires the department to develop plans by January 1, 2025, for improving pediatric-to-adult care transitions and maintaining Medicaid coverage continuity, and to establish performance standards and measures for contracts in 2025 with mechanisms to incentivize plan compliance.